Page last updated: 2024-09-02

ecteinascidin 743 and Chondrosarcoma

ecteinascidin 743 has been researched along with Chondrosarcoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elowsson, C; Krarup-Hansen, A; Mouritsen, LS; Safwat, A; Schack, LH1
Araki, N; Hiraga, H; Hiruma, T; Horiuchi, K; Kawai, A; Kikuta, K; Kunisada, T; Matsumine, A; Morioka, H; Nakayama, R; Nishimoto, K; Sugiura, H; Susa, M; Takahashi, M; Takahashi, S; Ueda, T; Yonemoto, T1
Choy, E; Duan, Z; Harmon, D; Hornicek, FJ; Mankin, H; Ryu, K; Schwab, J; Yang, C1
Bonomi, R; Broggini, M; Chiorino, G; D'Incalci, M; Faircloth, GT; Hornicek, FJ; Marchini, S; Marrazzo, E; Weissbach, L; Zaffaroni, M1

Trials

1 trial(s) available for ecteinascidin 743 and Chondrosarcoma

ArticleYear
Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma.
    BMC cancer, 2016, 07-14, Volume: 16

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Bone Neoplasms; Chondrosarcoma; Chondrosarcoma, Mesenchymal; Dioxoles; Disease-Free Survival; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasms, Connective and Soft Tissue; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome

2016

Other Studies

3 other study(ies) available for ecteinascidin 743 and Chondrosarcoma

ArticleYear
The Danish experience with trabectedin treatment for metastatic sarcoma: Importance of hyponatremia.
    Acta oncologica (Stockholm, Sweden), 2015, Volume: 54, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Chondrosarcoma; Denmark; Dioxoles; Female; Humans; Hyponatremia; Karnofsky Performance Status; Leiomyosarcoma; Liposarcoma; Middle Aged; Multivariate Analysis; Retrospective Studies; Sarcoma; Tetrahydroisoquinolines; Trabectedin; Young Adult

2015
ZNF93 increases resistance to ET-743 (Trabectedin; Yondelis) and PM00104 (Zalypsis) in human cancer cell lines.
    PloS one, 2009, Sep-09, Volume: 4, Issue:9

    Topics: Carrier Proteins; Cell Line, Tumor; Chondrosarcoma; Dioxoles; DNA Repair; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Oligonucleotide Array Sequence Analysis; Tetrahydroisoquinolines; Trabectedin; Zinc Fingers

2009
Molecular characterisation of two human cancer cell lines selected in vitro for their chemotherapeutic drug resistance to ET-743.
    European journal of cancer (Oxford, England : 1990), 2005, Volume: 41, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cell Line, Tumor; Chondrosarcoma; Dioxoles; Drug Resistance, Neoplasm; Female; Humans; Isoquinolines; Ovarian Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Tetrahydroisoquinolines; Trabectedin

2005